Marietta Wealth Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10M | Buy |
39,543
+1,097
| +3% | +$256K | 1.03% | 33 |
|
|
2026
Q1 | $9.4M | Buy |
38,446
+3,697
| +11% | +$861K | 1.12% | 33 |
|
|
2025
Q4 | $7.19M | Buy |
34,749
+19
| +0.1% | +$3.76K | 0.83% | 47 |
|
|
2025
Q3 | $6.44M | Buy |
34,730
+966
| +3% | +$166K | 0.79% | 57 |
|
|
2025
Q2 | $5.16M | Buy |
33,764
+1,389
| +4% | +$214K | 0.67% | 65 |
|
|
2025
Q1 | $5.37M | Buy |
32,375
+634
| +2% | +$99.2K | 0.79% | 62 |
|
|
2024
Q4 | $4.59M | Buy |
31,741
+145
| +0.5% | +$22.5K | 0.66% | 67 |
|
|
2024
Q3 | $5.12M | Buy |
31,596
+1,296
| +4% | +$206K | 0.74% | 62 |
|
|
2024
Q2 | $4.43M | Buy |
30,300
+1,686
| +6% | +$251K | 0.69% | 66 |
|
|
2024
Q1 | $4.53M | Buy |
28,614
+202
| +0.7% | +$32.2K | 0.75% | 61 |
|
|
2023
Q4 | $4.45M | Sell |
28,412
-437
| -2% | -$67K | 0.79% | 56 |
|
|
2023
Q3 | $4.49M | Sell |
28,849
-284
| -1% | -$46.9K | 0.89% | 52 |
|
|
2023
Q2 | $4.82M | Buy |
29,133
+524
| +2% | +$84.6K | 0.91% | 54 |
|
|
2023
Q1 | $4.43M | Sell |
28,609
-222
| -0.8% | -$35.8K | 0.94% | 53 |
|
|
2022
Q4 | $5.09M | Buy |
28,831
+269
| +0.9% | +$46.4K | 1.15% | 39 |
|
|
2022
Q3 | $4.67M | Buy |
28,562
+277
| +1% | +$46.9K | 1.16% | 37 |
|
|
2022
Q2 | $5.02M | Sell |
28,285
-460
| -2% | -$82K | 1.21% | 33 |
|
|
2022
Q1 | $5.09M | Buy |
28,745
+316
| +1% | +$53.8K | 1.07% | 40 |
|
|
2021
Q4 | $4.86M | Buy |
28,429
+814
| +3% | +$133K | 0.98% | 44 |
|
|
2021
Q3 | $4.46M | Buy |
27,615
+969
| +4% | +$165K | 0.97% | 41 |
|
|
2021
Q2 | $4.39M | Buy |
26,646
+841
| +3% | +$139K | 0.99% | 43 |
|
|
2021
Q1 | $4.24M | Buy |
25,805
+519
| +2% | +$84K | 1.06% | 39 |
|
|
2020
Q4 | $3.98M | Sell |
25,286
-360
| -1% | -$53.1K | 1.09% | 35 |
|
|
2020
Q3 | $3.82M | Sell |
25,646
-5,229
| -17% | -$774K | 1.19% | 31 |
|
|
2020
Q2 | $4.34M | Buy |
30,875
+418
| +1% | +$60.9K | 1.48% | 21 |
|
|
2020
Q1 | $3.99M | Buy |
30,457
+1,350
| +5% | +$192K | 1.56% | 18 |
|
|
2019
Q4 | $4.25M | Buy |
29,107
+252
| +0.9% | +$34.2K | 1.4% | 23 |
|
|
2019
Q3 | $3.73M | Buy |
28,855
+3,118
| +12% | +$411K | 1.36% | 27 |
|
|
2019
Q2 | $3.58M | Buy |
25,737
+277
| +1% | +$38.3K | 1.4% | 24 |
|
|
2019
Q1 | $3.56M | Buy |
25,460
+962
| +4% | +$129K | 1.46% | 19 |
|
|
2018
Q4 | $3.16M | Buy |
24,498
+359
| +1% | +$50.1K | 1.51% | 22 |
|
|
2018
Q3 | $3.33M | Buy |
24,139
+664
| +3% | +$88.2K | 1.47% | 17 |
|
|
2018
Q2 | $2.85M | Buy |
23,475
+877
| +4% | +$109K | 1.39% | 22 |
|
|
2018
Q1 | $2.9M | Buy |
22,598
+1,280
| +6% | +$173K | 1.52% | 20 |
|
|
2017
Q4 | $2.98M | Sell |
21,318
-804
| -4% | -$112K | 1.61% | 17 |
|
|
2017
Q3 | $2.88M | Buy |
22,122
+8
| +0% | +$1.06K | 1.61% | 16 |
|
|
2017
Q2 | $2.93M | Buy |
22,114
+1,267
| +6% | +$162K | 1.78% | 11 |
|
|
2017
Q1 | $2.6M | Buy |
20,847
+3,069
| +17% | +$367K | 1.72% | 11 |
|
|
2016
Q4 | $2.05M | Buy |
+17,778
| New | +$2.05M | 1.64% | 12 |
|
Other funds holding JNJ
Marietta Wealth Management's JNJ Position: Q2 2026 in Review
Marietta Wealth Management increased its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, buying an estimated $256K and bringing the position to 39,543 shares worth $10M. The position accounts for 1.03% of the portfolio, ranked #33.
Marietta Wealth Management first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Marietta Wealth Management held 39,543 shares of Johnson & Johnson worth $10M as of Q2 2026.
- Marietta Wealth Management bought 1,097 Johnson & Johnson shares in Q2 2026, an estimated $256K.
- Johnson & Johnson made up 1.03% of Marietta Wealth Management's portfolio in Q2 2026, its #33 holding.
- Marietta Wealth Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
- 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Marietta Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.